For Research Purposes Only

immune

LL-37 for Recurrent Infections

Emerging research, mechanistic understanding

How It Works

Human antimicrobial peptide with broad-spectrum activity against bacteria, viruses, and fungi.

Research Evidence

Well-studied as natural antimicrobial. Therapeutic use is emerging but promising.

Dosing Protocol

50-100mcg daily subcutaneously.

Important Considerations

  • !Natural human peptide
  • !May help chronic/recurrent infections
  • !Expensive

Frequently Asked Questions

Does LL-37 work for recurrent infections?

Well-studied as natural antimicrobial. Therapeutic use is emerging but promising. Research level: Emerging research, mechanistic understanding.

How does LL-37 help with recurrent infections?

Human antimicrobial peptide with broad-spectrum activity against bacteria, viruses, and fungi.

What is the LL-37 dosage for recurrent infections?

50-100mcg daily subcutaneously.

Is LL-37 safe for recurrent infections?

Key considerations: Natural human peptide. May help chronic/recurrent infections. Expensive. Always consult a healthcare provider.

How long until LL-37 works for recurrent infections?

Results vary by individual and condition severity. Most users report initial effects within 2-4 weeks, with full benefits developing over 8-12 weeks of consistent use.

Learn More

LL-37 guide unavailable
Disclaimer: This information is for educational and research purposes only. LL-37 is not FDA approved for this use. Consult qualified healthcare professionals.